Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Gene expression profiling of peripheral blood cells for early detection of breast cancer.

Aarøe J, Lindahl T, Dumeaux V, Saebø S, Tobin D, Hagen N, Skaane P, Lönneborg A, Sharma P, Børresen-Dale AL.

Breast Cancer Res. 2010;12(1):R7. doi: 10.1186/bcr2472. Epub 2010 Jan 15.

2.

Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer.

Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park NH, Chia D, Wong DT.

Gastroenterology. 2010 Mar;138(3):949-57.e1-7. doi: 10.1053/j.gastro.2009.11.010. Epub 2009 Nov 18.

3.

Early detection of breast cancer: new biomarker tests on the horizon?

Jotwani AC, Gralow JR.

Mol Diagn Ther. 2009 Dec 1;13(6):349-57. doi: 10.2165/11318220-000000000-00000. Review.

PMID:
19925032
4.

DNA methylation as a biomarker in breast cancer.

Martens JW, Margossian AL, Schmitt M, Foekens J, Harbeck N.

Future Oncol. 2009 Oct;5(8):1245-56. doi: 10.2217/fon.09.89. Review.

PMID:
19852739
5.

Salivary protein factors are elevated in breast cancer patients.

Brooks MN, Wang J, Li Y, Zhang R, Elashoff D, Wong DT.

Mol Med Rep. 2008 May-Jun;1(3):375-8.

6.

Detection of breast cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry tissue and serum protein profiling.

Gast MC, van Dulken EJ, van Loenen TK, Kingma-Vegter F, Westerga J, Flohil CC, Knol JC, Jimenez CR, van Gils CH, Wessels LF, Schellens JH, Beijnen JH.

Int J Biol Markers. 2009 Jul-Sep;24(3):130-41.

PMID:
19787623
7.

Salivary biomarkers for clinical applications.

Zhang L, Xiao H, Wong DT.

Mol Diagn Ther. 2009;13(4):245-59. doi: 10.2165/11317160-000000000-00000. Review.

PMID:
19712004
8.

Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection.

Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E, Wong DT.

Clin Cancer Res. 2009 Sep 1;15(17):5473-7. doi: 10.1158/1078-0432.CCR-09-0736. Epub 2009 Aug 25.

9.

Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer.

Lönneborg A, Aarøe J, Dumeaux V, Børresen-Dale AL.

Expert Rev Anticancer Ther. 2009 Aug;9(8):1115-23. doi: 10.1586/era.09.31. Review.

PMID:
19671031
10.

Expression of glutamate receptor subunits in human cancers.

Stepulak A, Luksch H, Gebhardt C, Uckermann O, Marzahn J, Sifringer M, Rzeski W, Staufner C, Brocke KS, Turski L, Ikonomidou C.

Histochem Cell Biol. 2009 Oct;132(4):435-45. doi: 10.1007/s00418-009-0613-1. Epub 2009 Jun 14.

PMID:
19526364
11.

Systemic disease-induced salivary biomarker profiles in mouse models of melanoma and non-small cell lung cancer.

Gao K, Zhou H, Zhang L, Lee JW, Zhou Q, Hu S, Wolinsky LE, Farrell J, Eibl G, Wong DT.

PLoS One. 2009 Jun 11;4(6):e5875. doi: 10.1371/journal.pone.0005875.

12.

Salivary biomarkers for the detection of malignant tumors that are remote from the oral cavity.

Bigler LR, Streckfus CF, Dubinsky WP.

Clin Lab Med. 2009 Mar;29(1):71-85. doi: 10.1016/j.cll.2009.01.004. Review.

PMID:
19389552
13.

A transcriptional sketch of a primary human breast cancer by 454 deep sequencing.

Guffanti A, Iacono M, Pelucchi P, Kim N, Soldà G, Croft LJ, Taft RJ, Rizzi E, Askarian-Amiri M, Bonnal RJ, Callari M, Mignone F, Pesole G, Bertalot G, Bernardi LR, Albertini A, Lee C, Mattick JS, Zucchi I, De Bellis G.

BMC Genomics. 2009 Apr 20;10:163. doi: 10.1186/1471-2164-10-163.

14.

Identification of modulated genes by three classes of chemopreventive agents at preneoplastic stages in a p53-null mouse mammary tumor model.

Abba MC, Hu Y, Levy CC, Gaddis S, Kittrell FS, Hill J, Bissonnette RP, Brown PH, Medina D, Aldaz CM.

Cancer Prev Res (Phila). 2009 Feb;2(2):175-84. doi: 10.1158/1940-6207.CAPR-08-0104. Epub 2009 Jan 27.

15.

Clinical proteomics in breast cancer: a review.

Gast MC, Schellens JH, Beijnen JH.

Breast Cancer Res Treat. 2009 Jul;116(1):17-29. doi: 10.1007/s10549-008-0263-3. Epub 2008 Dec 11. Review.

PMID:
19082706
16.

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design.

Pepe MS, Feng Z, Janes H, Bossuyt PM, Potter JD.

J Natl Cancer Inst. 2008 Oct 15;100(20):1432-8. doi: 10.1093/jnci/djn326. Epub 2008 Oct 7.

17.

Salivary proteomics for oral cancer biomarker discovery.

Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, Elashoff D, Wei R, Loo JA, Wong DT.

Clin Cancer Res. 2008 Oct 1;14(19):6246-52. doi: 10.1158/1078-0432.CCR-07-5037.

18.

Discovery of novel tumor suppressor p53 response elements using information theory.

Lyakhov IG, Krishnamachari A, Schneider TD.

Nucleic Acids Res. 2008 Jun;36(11):3828-33. doi: 10.1093/nar/gkn189. Epub 2008 May 21.

19.

Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer.

Anderson KS, Ramachandran N, Wong J, Raphael JV, Hainsworth E, Demirkan G, Cramer D, Aronzon D, Hodi FS, Harris L, Logvinenko T, LaBaer J.

J Proteome Res. 2008 Apr;7(4):1490-9. doi: 10.1021/pr700804c. Epub 2008 Feb 27.

20.

Breast cancer related proteins are present in saliva and are modulated secondary to ductal carcinoma in situ of the breast.

Streckfus CF, Mayorga-Wark O, Arreola D, Edwards C, Bigler L, Dubinsky WP.

Cancer Invest. 2008 Mar;26(2):159-67. doi: 10.1080/07357900701783883.

PMID:
18259946
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk